Kennel cough merck vet manual

Source: Merck Vet Manual Kennel Cough, or canine infectious tracheobronchitis, is a highly contagious respiratory disease in dogs. Found worldwide, the disease will affect a relatively high percentage of dogs in their lifetime. Merck and the Merck Veterinary Manual. Merck Co., Inc., Kenilworth, NJ, USA is a global healthcare leader working to help the world be well. From developing new therapies that treat and prevent disease to helping people in need, we are committed to improving health and well-being around the world. Kennel Cough (Infectious Tracheobronchitis) in Dogs. Kennel cough results from an inflammation of the upper airways. It is fully discussed in this chapter under Tracheobronchitis. Tracheobronchitis (Bronchitis) in Dogs Tracheobronchitis is a sudden or longterm inflammation of the trachea and bronchial airways; it may also extend into the lungs.

The Merck Veterinary Manual recommends a dosage of 5 - 10 mg of doxycycline per day for dogs battling infections like kennel cough. Dosage may also be recommended by your vet at 3 - 5 mg twice daily. However, for tick-borne diseases dosage may be higher. What is kennel cough? It is a mild, self-limiting disease but may progress to fatal bronchopneumonia in puppies or to chronic bronchitis in debilitated adult or aged dogs. The illness spreads rapidly among susceptible dogs housed in close confinement (eg, veterinary hospitals or kennels). Canine parainfluenza virus, canine adenovirus 2 (CAV Merck and the Merck Veterinary Manual. Merck Co., Inc., Kenilworth, NJ, USA is a global healthcare leader working to help the world be well. From developing new therapies that treat and prevent disease to helping people in need, we are committed to improving health and well-being around the world.

Kennel Cough (Infectious Tracheobronchitis) in Dogs. Kennel cough results from an inflammation of the upper airways. It is fully discussed in this chapter under Tracheobronchitis. Tracheobronchitis (Bronchitis) in Dogs Tracheobronchitis is a sudden or longterm inflammation of the trachea and bronchial airways; it may also extend into the lungs. MSD and the MSD Veterinary Manual Merck Co., Inc., Kenilworth, NJ, USA (known as MSD outside of the US and Canada) is a global healthcare leader working to help the world be well. From developing new therapies that treat and prevent disease to helping people in need, we are committed to improving health and well-being around the world. The Merck Veterinary Manual was first published in as a service to the community. The legacy of this great resource continues as the Merck Veterinary Manual in the US and Canada and the MSD Manual outside of North America.